Are you Dr. Rowbotham?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 70 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1701 Divisadero St
San Francisco, CA 94115Phone+1 415-885-7899Fax+1 415-885-7855
Summary
- Dr. Michael Rowbotham, MD is a board certified neurologist in San Francisco, California. He is currently licensed to practice medicine in California. He is affiliated with California Pacific Medical Center and UCSF Medical Center.
Education & Training
- University of California (San Francisco)Residency, Neurology, 1986 - 1988
- Boston University Medical CenterResidency, Neurology, 1984 - 1986
- University of California San Francisco School of MedicineClass of 1979
Certifications & Licensure
- CA State Medical License 1981 - 2025
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Levetiracetam for Treatment of Pain Associated With Fibromyalgia Start of enrollment: 2004 Mar 01
- Naltrexone Effects on Alcohol Intake Start of enrollment: 2005 Feb 01
- Analgesic Tolerance to Repeated Doses of Subcutaneous Morphine Start of enrollment: 2005 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 311 citationsTopical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment studyBradley S. Galer, Michael C. Rowbotham, Jill Perander, Erika Friedman
Pain. 1999-04-01 - 339 citationsBoth intravenous lidocaine and morphine reduce the pain of postherpetic neuralgiaMichael C. Rowbotham, Lori A. Reisner-Keller, Howard L. Fields
Neurology. 1991-07-01 - 350 citationsLidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgiaMichael C. Rowbotham, Pamela Stitzlein Davies, Christina Verkempinck, Bradley S. Galer
Pain. 1996-04-01
Press Mentions
- Opioid Tolerance, Hyperalgesia Increase Following Stable DosingFebruary 19th, 2020
- CPMC Research Institute Scientific Director Receives Top Accolades from the American Academy of NeurologyApril 14th, 2016
- Making Inroads in Fight Against Shingles PainFebruary 15th, 2000
- Join now to see all
Grant Support
- Chronic Neuropathic Pain Mechanisms And ManagementNational Institute Of Neurological Disorders And Stroke2000–2004
- Pain &Neural Dysfunction From Acute Herpes ZosterNational Institute Of Neurological Disorders And Stroke2000–2002
- Opioid Responsivity/ Analgesic Tolerance In Chronic PainNational Institute Of Neurological Disorders And Stroke2000–2002
- Mechanisms Of Pain And AnalgesiaNational Institute Of Neurological Disorders And Stroke1996–1999
- Opioid Analgesia And Tolerance DevelopmentNational Institute On Drug Abuse1997–1998